For more than 140 years, we have worked tirelessly to develop and deliver trusted medicines that meet real needs.
On this page you will find Product Monographs and Patient Medication Information (also known as Consumer Information). You will also find instructions on how to use our devices. Documents provided here are for informational use and for residents of Canada only.
Lilly Canada is committed to keeping people informed about the availability of our medicines. In the event of a shortage or discontinuation, we will post an update on the website of Drug Shortages Canada.
If you are a customer and have questions about Lilly medicines, please call our Customer Response Centre at 1-888-545-5972 or submit your questions using this online form. If you are seeking medical advice, contact your health care provider.
Re-usable Devices – Humalog® and Humulin® Family of Products
Instructions for Use - HumaPen® Luxura®
HumaPen® Luxura® pens are no longer distributed in Canada.
Instructions for Use - HumaPen Luxura® HD
HumaPen® Luxura® HD pens are no longer distributed in Canada.
Instructions for Use - HumaPen Savvio®
® Registered trademark owned by Eli Lilly and Company; used under license.
TM Trademark owned by Eli Lilly and Company; used under license.
®* Registered trademark of ImClone LLC; used under license.
®+ Registered trademark of Boehringer Ingelheim International GmbH; used under license. Basaglar, Glyxambi, Jardiance, Jentadueto, Synjardy and Trajenta are part of the Boehringer Ingelheim–Lilly Alliance.
®± Registered trademark owned by R.P. Scherer Technologies, Inc., a Catalent Pharma Solutions Company